Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 4Osteoporosis 3Pain 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 1Hypercalcemia 1Humoral Hypercalcemia Of Malignancy 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Zoledronic Acid × Clear all
NCT00458796 2022-05-27

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

University of Leeds

Phase NA Terminated
1,500 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡